Osteopontin expression in human and murine obesity: Extensive local up-regulation in adipose tissue but minimal systemic alterations

Endocrinology

Volumn 149, Issue 3, 2008, Pages 1350-1357

  Kiefer, Florian W ^a   Zeyda, Maximilian ^a   Todoric, Jelena ^a   Huber, Joakim ^a   Geyeregger, René ^a   Weichhart, Thomas ^a   Aszmann, Oskar ^a   Ludvik, Bernhard ^a   Silberhumer, Gerd R ^a   Prager, Gerhard ^a   Stulnig, Thomas M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOPONTIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; LIPID DIET; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ADIPOSE TISSUE; ADOLESCENT; ADULT; ANIMALS; CASE-CONTROL STUDIES; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIVER; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; OBESITY; OSTEOPONTIN; PROTEIN ISOFORMS; SUBCUTANEOUS FAT;

EID: 40849097785     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-1312     Document Type: Article

References (53)

1. Despres JP, Lemieux I 2006 Abdominal obesity and metabolic syndrome. Nature 444:881-887
2. Kahn SE, Zinman B, Haffner SM, O'Neill MC, Kravitz BG, Yu D, Freed MI, Herman WH, Holman RR, Jones NP, Lachin JM, Viberti GC 2006 Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes 55:2357-2364
3. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B 2006 Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17:4-12
4. Greenberg AS, Obin MS 2006 Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 83:461S-465S
5. Shoelson SE, Lee J, Goldfine AB 2006 Inflammation and insulin resistance. J Clin Invest 116:1793-1801
6. Hotamisligil GS, Shargill NS, Spiegelman BM 1993 Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259:87-91
7. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H 2003 Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-1830
8. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW 2003 Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808
9. Clement K, Viguerie N, Poitou C, Carette C, Pelloux V, Curat CA, Sicard A, Rome S, Benis A, Zucker JD, Vidal H, Laville M, Barsh GS, Basdevant A, Stich V, Cancello R, Langin D 2004 Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 18:1657-1669
10. Fain JN 2006 Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 74:443-477
11. Cancello R, Tordjman J, Poitou C, Guilhem G, Bouillot JL, Hugol D, Coussieu C, Basdevant A, Hen AB, Bedossa P, Guerre-Millo M, Clement K 2006 Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 55:1554-1561
12. Curat CA, Wegner V, Sengenes C, Miranville A, Tonus C, Busse R, Bouloumie A 2006 Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 49:744-747
13. Zeyda M, Farmer D, Todoric J, Aszmann O, Speiser M, Györi G, Zlabinger GJ, Stulnig TM 2007 Human adipose tissue macrophages are of an anti inflammatory phenotype but capable of excessive pro inflammatory mediator production. Int J Obes (Lond) 31:1420-1428
14. Saitoh Y, Kuratsu J, Takeshima H, Yamamoto S, Ushio Y 1995 Expression of osteopontin in human glioma. Its correlation with the malignancy. Lab Invest 72:55-63
15. Young MF, Kerr JM, Termine JD, Wewer UM, Wang MG, McBride OW, Fisher LW 1990 cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN). Genomics 7:491-502
16. Mazzali M, Kipari T, Ophascharoensuk V, Wesson JA, Johnson R, Hughes J 2002 Osteopontin-a molecule for all seasons. QJM 95:3-13
17. Standal T, Borset M, Sundan A 2004 Role of osteopontin in adhesion, migration, cell survival and bone remodeling. Exp Oncol 26:179-184
18. Rangaswami H, Bulbule A, Kundu GC 2006 Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol 16:79-87
19. Xu G, Nie H, Li N, Zheng W, Zhang D, Feng G, Ni L, Xu R, Hong J, Zhang JZ 2005 Role of osteopontin in amplification and perpetuation of rheumatoid synovitis. J Clin Invest 115:1060-1067
20. Teti A, Farina AR, Villanova I, Tiberio A, Tacconelli A, Sciortino G, Chambers AF, Gulino A, Mackay AR 1998 Activation of MMP-2 by human GCT23 giant cell tumour cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent. Int J Cancer 77:82-93
21. Xu G, Sun W, He D, Wang L, Zheng W, Nie H, Ni L, Zhang D, Li N, Zhang J 2005 Overexpression of osteopontin in rheumatoid synovial mononuclear cells is associated with joint inflammation, not with genetic polymorphism. J Rheumatol 32:410-416
22. Isoda K, Kamezawa Y, Ayaori M, Kusuhara M, Tada N, Ohsuzu F 2003 Osteopontin transgenic mice fed a high-cholesterol diet develop early fatty-streak lesions. Circulation 107:679-681
23. Matsui Y, Jia N, Okamoto H, Kon S, Onozuka H, Akino M, Liu L, Morimoto J, Rittling SR, Denhardt D, Kitabatake A, Uede T 2004 Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy. Hypertension 43:1195-1201
24. Quilliot D, Alla F, Bohme P, Bruntz JF, Hammadi M, Dousset B, Ziegler O, Zannad F 2005 Myocardial collagen turnover in normotensive obese patients: relation to insulin resistance. Int J Obes (Lond) 29:1321-1328
25. McGill Jr HC, McMahan CA, Herderick EE, Zieske AW, Malcom GT, Tracy RE, Strong JP 2002 Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 105:2712-2718
26. Kase S, Yokoi M, Saito W, Furudate N, Ohgami K, Kitamura M, Kitaichi N, Yoshida K, Kase M, Ohno S, Uede T 2007 Increased osteopontin levels in the vitreous of patients with diabetic retinopathy. Ophthalmic Res 39:143-147
27. Lai CF, Seshadri V, Huang K, Shao JS, Cai J, Vattikuti R, Schumacher A, Loewy AP, Denhardt DT, Rittling SR, Towler DA 2006 An osteopontin-NADPH oxidase signaling cascade promotes pro-matrix metalloproteinase 9 activation in aortic mesenchymal cells. Circ Res 98:1479-1489
28. Todoric J, Loffler M, Huber J, Bilban M, Reimers M, Kadl A, Zeyda M, Waldhausl W, Stulnig TM 2006 Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsaturated fatty acids. Diabetologia 49:2109-2119
29. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW 2004 Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145:2273-2282
30. Zeyda M, Stulnig TM 2007 Adipose tissue macrophages. Immunol Lett 112:61-67
31. Sahai A, Malladi P, Pan X, Paul R, Melin-Aldana H, Green RM, Whitington PF 2004 Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. Am J Physiol Gastrointest Liver Physiol 287:G1035-G1043
32. Gomez-Ambrosi J, Catalan V, Ramirez B, Rodriguez A, Colina I, Silva C, Rotellar F, Mugueta C, Gil MJ, Cienfuegos JA, Salvador J, Fruhbeck G 2007 Plasma osteopontin levels and expression in adipose tissue are increased in obesity. J Clin Endocrinol Metab 92:3719-3727
33. Nomiyama T, Perez-Tilve D, Ogawa D, Gizard F, Zhao Y, Heywood EB, Jones KL, Kawamori R, Cassis LA, Tschop MH, Bruemmer D 2007 Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest 117:2877-2888
34. He B, Mirza M, Weber GF 2006 An osteopontin splice variant induces anchorage independence in human breast cancer cells. Oncogene 25:2192-2202
35. Weber GF, Zawaideh S, Hikita S, Kumar VA, Cantor H, Ashkar S 2002 Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation. J Leukoc Biol 72:752-761
36. O'Regan AW, Hayden JM, Berman JS 2000 Osteopontin augments CD3-mediated interferon-gamma and CD40 ligand expression by T cells, which results in IL-12 production from peripheral blood mononuclear cells. J Leukoc Biol 68:495-502
37. Scatena M, Liaw L, Giachelli CM 2007 Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 27:2302-2309
38. Wu H, Ghosh S, Perrard XD, Feng L, Garcia GE, Perrard JL, Sweeney JF, Peterson LE, Chan L, Smith CW, Ballantyne CM 2007 T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 115:1029-1038
39. Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M 1998 Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 152:353-358
40. Yamamoto N, Sakai F, Kon S, Morimoto J, Kimura C, Yamazaki H, Okazaki I, Seki N, Fujii T, Uede T 2003 Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis. J Clin Invest 112:181-188
41. Weiss JM, Renkl AC, Maier CS, Kimmig M, Liaw L, Ahrens T, Kon S, Maeda M, Hotta H, Uede T, Simon JC 2001 Osteopontin is involved in the initiation of cutaneous contact hypersensitivity by inducing Langerhans and dendritic cell migration to lymph nodes. J Exp Med 194:1219-1229
42. Renkl AC, Wussler J, Ahrens T, Thoma K, Kon S, Uede T, Martin SF, Simon JC, Weiss JM 2005 Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1-polarizing phenotype. Blood 106:946-955
43. Chavey C, Mari B, Monthouel MN, Bonnafous S, Anglard P, Van Obberghen E, Tartare-Deckert S 2003 Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J Biol Chem 278:11888-11896
44. Huber J, Loffler M, Bilban M, Reimers M, Kadl A, Todoric J, Zeyda M, Geyeregger R, Schreiner M, Weichhart T, Leitinger N, Waldhausl W, Stulnig TM 2007 Prevention of high-fat diet-induced adipose tissue remodeling in obese diabetic mice by n-3 polyunsaturated fatty acids. Int J Obes (Lond) 31:1004-1013
45. Hwang SM, Lopez CA, Heck DE, Gardner CR, Laskin DL, Laskin JD, Denhardt DT 1994 Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells. J Biol Chem 269:711-715
46. Yu XQ, Fan JM, Nikolic-Paterson DJ, Yang N, Mu W, Pichler R, Johnson RJ, Atkins RC, Lan HY 1999 IL-1 up-regulates osteopontin expression in experimental crescentic glomerulonephritis in the rat. Am J Pathol 154:833-841
47. Guo H, Cai CQ, Schroeder RA, Kuo PC 2001 Osteopontin is a negative feedback regulator of nitric oxide synthesis in murine macrophages. J Immunol 166:1079-1086
48. Esposito K, Pontillo A, Giugliano F, Giugliano G, Marfella R, Nicoletti G, Giugliano D 2003 Association of low interleukin-10 levels with the metabolic syndrome in obese women. J Clin Endocrinol Metab 88:1055-1058
49. Chung S, Lapoint K, Martinez K, Kennedy A, Boysen Sandberg M, McIntosh MK 2006 Preadipocytes mediate LPS-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. Endocrinology 147:5340-5351
50. Kawamura H, Yokote K, Asaumi S, Kobayashi K, Fujimoto M, Maezawa Y, Saito Y, Mori S 2004 High glucose-induced upregulation of osteopontin is mediated via Rho/Rho kinase pathway in cultured rat aortic smooth muscle cells. Arterioscler Thromb Vasc Biol 24:276-281
51. Permana PA, Menge C, Reaven PD 2006 Macrophage-secreted factors induce adipocyte inflammation and insulin resistance. Biochem Biophys Res Commun 341:507-514
52. Jager J, Gremeaux T, Cormont M, Le Marchand-Brustel Y, Tanti JF 2007 Interleukin-1β-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 148:241-251
53. Lumeng CN, Deyoung SM, Saltiel AR 2007 Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. Am J Physiol Endocrinol Metab 292:E166-E174